CAM
LLY icon

Concorde Asset Management’s Eli Lilly LLY Stock Holding History

Concorde Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$783K Buy
652
+17
+3% +$17.4K 0.45% 43
2026
Q1 		$584K Sell
635
-255
-29% -$259K 0.29% 78
2025
Q4 		$956K Buy
890
+9
+1% +$8.61K 0.38% 49
2025
Q3 		$717K Buy
+881
New +$656K 0.3% 69
2025
Q1 		$765K Buy
1,015
+115
+13% +$95.7K 0.41% 31
2024
Q4 		$695K Sell
900
-206
-19% -$171K 0.36% 46
2024
Q3 		$980K Sell
1,106
-4
-0.4% -$3.6K 0.55% 31
2024
Q2 		$1.01M Buy
1,110
+133
+14% +$106K 0.62% 27
2024
Q1 		$760K Buy
977
+21
+2% +$14.9K 0.52% 30
2023
Q4 		$557K Sell
956
-92
-9% -$53.7K 0.38% 44
2023
Q3 		$563K Buy
1,048
+35
+3% +$18K 0.51% 41
2023
Q2 		$475K Buy
+1,013
New +$425K 0.44% 44
2023
Q1 		– Sell
-1,009
Closed -$369K – 121
2022
Q4 		$369K Sell
1,009
-1
-0.1% -$355 0.33% 73
2022
Q3 		$327K Buy
+1,010
New +$320K 0.37% 81
2022
Q2 		– Sell
-976
Closed -$279K – 145
2022
Q1 		$279K Buy
+976
New +$251K 0.19% 114
2021
Q4 		– Sell
-929
Closed -$214K – 186
2021
Q3 		$214K Buy
929
+45
+5% +$11.1K 0.12% 177
2021
Q2 		$203K Buy
+884
New +$178K 0.11% 187
2015
Q3 		– Sell
-2,926
Closed -$221K – 114
2015
Q2 		$221K Sell
2,926
-251
-8% -$19.1K 0.28% 89
2015
Q1 		$230K Buy
3,177
+160
+5% +$11.4K 0.26% 99
2014
Q4 		$207K Buy
+3,017
New +$204K 0.26% 86

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Concorde Asset Management's LLY Position: Q2 2026 in Review

Concorde Asset Management increased its Eli Lilly (LLY) stake by 2.7% in Q2 2026, buying an estimated $17.4K and bringing the position to 652 shares worth $783K. The position accounts for 0.45% of the portfolio, ranked #43.

Concorde Asset Management first reported a position in LLY in Q4 2014 and has held it in 20 quarters since. The position peaked at $1.01M in Q2 2024. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Concorde Asset Management held 652 shares of Eli Lilly worth $783K as of Q2 2026.
  • Concorde Asset Management bought 17 Eli Lilly shares in Q2 2026, an estimated $17.4K.
  • Eli Lilly made up 0.45% of Concorde Asset Management's portfolio in Q2 2026, its #43 holding.
  • Concorde Asset Management first reported a position in Eli Lilly in Q4 2014 and has held it in 20 quarters since.
  • Concorde Asset Management's Eli Lilly position peaked at $1.01M in Q2 2024.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Concorde Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.